JP2022514152A5 - - Google Patents
Info
- Publication number
- JP2022514152A5 JP2022514152A5 JP2021518888A JP2021518888A JP2022514152A5 JP 2022514152 A5 JP2022514152 A5 JP 2022514152A5 JP 2021518888 A JP2021518888 A JP 2021518888A JP 2021518888 A JP2021518888 A JP 2021518888A JP 2022514152 A5 JP2022514152 A5 JP 2022514152A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- item
- day
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024114026A JP2024133735A (ja) | 2018-10-04 | 2024-07-17 | Ｉｖ型コラーゲン疾患の処置のためのビフェニルスルホンアミド化合物 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862741270P | 2018-10-04 | 2018-10-04 | |
| US62/741,270 | 2018-10-04 | ||
| US201962853904P | 2019-05-29 | 2019-05-29 | |
| US62/853,904 | 2019-05-29 | ||
| US201962894559P | 2019-08-30 | 2019-08-30 | |
| US62/894,559 | 2019-08-30 | ||
| PCT/US2019/054559 WO2020072814A1 (en) | 2018-10-04 | 2019-10-03 | Biphenyl sulfonamide compounds for the treatment of type iv collagen diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024114026A Division JP2024133735A (ja) | 2018-10-04 | 2024-07-17 | Ｉｖ型コラーゲン疾患の処置のためのビフェニルスルホンアミド化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514152A JP2022514152A (ja) | 2022-02-10 |
| JP2022514152A5 true JP2022514152A5 (cg-RX-API-DMAC10.html) | 2022-10-06 |
| JP7524167B2 JP7524167B2 (ja) | 2024-07-29 |
Family
ID=68318947
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518888A Active JP7524167B2 (ja) | 2018-10-04 | 2019-10-03 | Ｉｖ型コラーゲン疾患の処置のためのビフェニルスルホンアミド化合物 |
| JP2024114026A Pending JP2024133735A (ja) | 2018-10-04 | 2024-07-17 | Ｉｖ型コラーゲン疾患の処置のためのビフェニルスルホンアミド化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024114026A Pending JP2024133735A (ja) | 2018-10-04 | 2024-07-17 | Ｉｖ型コラーゲン疾患の処置のためのビフェニルスルホンアミド化合物 |
Country Status (13)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019530713A (ja) | 2016-10-13 | 2019-10-24 | レトロフィン， インコーポレイテッド | 腎臓疾患または障害を処置するためのビフェニルスルホンアミド化合物 |
| WO2022246200A1 (en) * | 2021-05-21 | 2022-11-24 | Travere Therapeutics, Inc. | Methods of treating kidney diseases or disorders |
| WO2022266370A1 (en) * | 2021-06-17 | 2022-12-22 | Aria Pharmaceuticals, Inc. | Sparsentan for treating idiopathic pulmonary fibrosis |
| JP2025183466A (ja) * | 2022-11-11 | 2025-12-17 | 株式会社アークメディスン | 化合物、エンドセリンａ受容体拮抗剤、アンジオテンシンｉｉタイプ１受容体拮抗剤及び医薬組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID26984A (id) | 1998-07-06 | 2001-02-22 | Bristol Myers Squibb Co | Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda |
| US6638937B2 (en) | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| WO2001044239A2 (en) | 1999-12-15 | 2001-06-21 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| WO2010114801A1 (en) | 2009-03-31 | 2010-10-07 | Ligand Pharmaceuticals Inc. | Oral formulations of diphenylsulfonamide endothelin and angiotensin ii receptor agonists to treat elevated blood pressure and diabetic nephropathy |
| WO2010135350A2 (en) | 2009-05-20 | 2010-11-25 | Pharmacopeia, Llc | Biphenyl intermediate compounds and methods for the preparation of a dual angiotensin ii and endothelin a receptor antagonist |
| US9719981B2 (en) | 2012-08-17 | 2017-08-01 | Father Flanagan's Boys' Home | RAC1 inhibitors for the treatment of alport glomerular disease |
| US10744178B2 (en) * | 2014-08-21 | 2020-08-18 | Stealth Biotherapeutics Corp | Methods and compositions for the prevention and treatment of disease |
| CN109982718A (zh) * | 2016-09-19 | 2019-07-05 | 阿托恩波罗斯生命科学 | 基于环糊精的聚合物、方法、组合物及其应用 |
| JP2019530713A (ja) * | 2016-10-13 | 2019-10-24 | レトロフィン， インコーポレイテッド | 腎臓疾患または障害を処置するためのビフェニルスルホンアミド化合物 |
| BR112021012226A2 (pt) | 2018-12-21 | 2021-09-08 | Travere Therapeutics, Inc. | Composições de esparsentano amorfo |
-
2019
- 2019-10-03 JP JP2021518888A patent/JP7524167B2/ja active Active
- 2019-10-03 WO PCT/US2019/054559 patent/WO2020072814A1/en not_active Ceased
- 2019-10-03 CN CN201980079773.4A patent/CN113286587A/zh active Pending
- 2019-10-03 ES ES19791401T patent/ES3057657T3/es active Active
- 2019-10-03 CA CA3114434A patent/CA3114434A1/en active Pending
- 2019-10-03 MA MA053817A patent/MA53817A/fr unknown
- 2019-10-03 US US16/592,633 patent/US11207299B2/en active Active
- 2019-10-03 EP EP19791401.3A patent/EP3860594B1/en active Active
- 2019-10-03 BR BR112021006132-0A patent/BR112021006132A2/pt unknown
- 2019-10-03 MX MX2021003606A patent/MX2021003606A/es unknown
- 2019-10-03 IL IL327175A patent/IL327175A/en unknown
- 2019-10-03 AU AU2019354784A patent/AU2019354784B2/en active Active
- 2019-10-03 KR KR1020217010358A patent/KR102902972B1/ko active Active
-
2021
- 2021-04-01 IL IL281965A patent/IL281965B2/en unknown
-
2024
- 2024-07-17 JP JP2024114026A patent/JP2024133735A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6795571B2 (ja) | グリブリドおよび他の薬剤の静脈内投与方法 | |
| Morse et al. | The treatment of sarcoidosis with chloroquine | |
| EA022040B1 (ru) | Применение бетанехола для лечения ксеростомии | |
| US20210386858A1 (en) | Mucoadhesive compositions and uses thereof | |
| JP3221880B2 (ja) | 抗うつ作用を有する医薬組成物としての２‐アミノ‐６‐ｎ‐プロピル‐アミノ‐４，５，６，７‐テトラヒドロベンゾチアゾールの使用 | |
| EP1274402A1 (en) | Pharmaceutical composition for the controlled release of paracetamol | |
| JP2010518171A (ja) | 非冠微小血管疾患の処置のためのラノラジンの使用 | |
| Storms et al. | Effectiveness of azelastine nasal solution in seasonal allergic rhinitis | |
| JP2001517628A (ja) | 注意欠陥／多動障害の治療法 | |
| JP2021520400A (ja) | エダラボン医薬組成物 | |
| TW202200142A (zh) | 阿立哌唑注射用製劑之投予方法 | |
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| JP2002505280A (ja) | 一過性熱感を軽減するための塩酸フルオキセチン | |
| JPS59181224A (ja) | 安定なインタ−フエロン製剤の製法 | |
| JP5680412B2 (ja) | レオヌリンの使用およびその組成物 | |
| JPH01503146A (ja) | 身体組織の治療方法および身体組織への医薬の投与方法 | |
| JP2021152002A5 (cg-RX-API-DMAC10.html) | ||
| Eisler et al. | Absorption of levodopa after rectal administration | |
| JP2024529777A (ja) | ＡＲＮｉとカルシウムイオンアンタゴニストとの医薬組成物および応用 | |
| JP2004149495A (ja) | 電解質代謝および酸塩基平衡を管理する方法 | |
| JPH0473413B2 (cg-RX-API-DMAC10.html) | ||
| JP2002502863A (ja) | 炭酸脱水酵素抑制剤を用いた脳浮腫の治療 | |
| JP2002308764A (ja) | 眼科用医薬組成物 | |
| Berglund et al. | A within‐patient comparison of alprenolol and propranolol in hypertension | |
| JP5172678B2 (ja) | 安定化および保存化したケトチフェン含有眼用組成物 |